Citation Impact
Citing Papers
Anti-Markovnikov alkene oxidation by metal-oxo–mediated enzyme catalysis
2017 StandoutScienceNobel
Reconstituting Organ-Level Lung Functions on a Chip
2010 StandoutScience
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Understanding organofluorine chemistry. An introduction to the C–F bond
2007 Standout
Visible light photoredox catalysis: applications in organic synthesis
2010 Standout
Chemogenetic control of gene expression and cell signaling with antiviral drugs
2018
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes
2002
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes
2003
The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
2015
Resistance Analysis of Hepatitis C Virus Genotype 1 Prior Treatment Null Responders Receiving Daclatasvir And Asunaprevir
2013
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Selection of boron reagents for Suzuki–Miyaura coupling
2013 Standout
New horizons in hepatitis C antiviral therapy with direct-acting antivirals
2013
Naringin is a Major and Selective Clinical Inhibitor of Organic Anion-Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice
2007
Catalysis for fluorination and trifluoromethylation
2011 StandoutNature
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Fluorine in Medicinal Chemistry
2015
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
2008 Standout
Mechanism-Based Inhibition: Deriving KI and kinact Directly from Time-Dependent IC50 Values
2009
Immortal Activated Human Hepatic Stellate Cells Generated by Ectopic Telomerase Expression
2002
The retinoid X receptors and their ligands
2011
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
2001
Tunable and reversible drug control of protein production via a self-excising degron
2015 Nobel
Fruit juice inhibition of uptake transport: a new type of food–drug interaction
2010
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Halogenated ligands and their interactions with amino acids: Implications for structure–activity and structure–toxicity relationships
2008
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
2014
Microfluidic organs-on-chips
2014 Standout
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
2015 StandoutNobel
Polyphenols: food sources and bioavailability
2004 Standout
Influence of Dietary Components on the Gastrointestinal Metabolism and Transport of Drugs
2000
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Hepatitis C Virus-Specific Directly Acting Antiviral Drugs
2013
The Polar Hydrophobicity of Fluorinated Compounds
2004
Determination of a Degradation Constant for CYP3A4 by Direct Suppression of mRNA in a Novel Human Hepatocyte Model, HepatoPac
2015
Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity
2008
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Microscale culture of human liver cells for drug development
2007
Herbal bioactivation: The good, the bad and the ugly
2003
Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components
2001
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Biological effects of essential oils – A review
2007 Standout
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
2014
Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure
2001
Current race in the development of DAAs (direct-acting antivirals) against HCV
2014
Fingerprinting food: current technologies for the detection of food adulteration and contamination
2012 Standout
Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets
2015
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Fluorine in medicinal chemistry
2007 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
2016 Standout
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Protease inhibitor therapy for hepatitis C virus-infection
2018
Transport, metabolism and elimination mechanisms of anti-HIV agents
1999
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Modeling hepatitis C virus infection using human induced pluripotent stem cells
2012 StandoutNobel
Oxadiazoles in Medicinal Chemistry
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Structural Analysis of Asunaprevir Resistance in HCV NS3/4A Protease
2014
Boron Reagents in Process Chemistry: Excellent Tools for Selective Reductions
2006
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Thyroid Hormone Regulation of Metabolism
2014 Standout
In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450
2017
Structural and Biochemical Studies of a Fluoroacetyl-CoA-Specific Thioesterase Reveal a Molecular Basis for Fluorine Selectivity
2010 StandoutNobel
Augmentation of Myocardial Production of 15-Epi-Lipoxin-A 4 by Pioglitazone and Atorvastatin in the Rat
2006
ETCM: an encyclopaedia of traditional Chinese medicine
2018 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Fluorine in Peptide Design and Protein Engineering
2005
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Aromatic Trifluoromethylation with Metal Complexes
2011 Standout
ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties
2021 Standout
The Halogen Bond
2016 Standout
Photodegradation of the pharmaceuticals atorvastatin, carbamazepine, levofloxacin, and sulfamethoxazole in natural waters
2005
Metal–Organic Frameworks in Biomedicine
2011 Standout
Visible Light Photoredox Catalysis with Transition Metal Complexes: Applications in Organic Synthesis
2013 Standout
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
Aquatic persistence of eight pharmaceuticals in a microcosm study
2004
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Works of Michael Sinz being referenced
Current Industrial Practices in Assessing CYP450 Enzyme Induction: Preclinical and Clinical
2008
Cytochrome P450 reaction-phenotyping: an industrial perspective
2007
In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective
2009
Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes
2000
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole
2006
Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding Sites
2007
Comparative Effects of Thiazolidinediones on in Vitro P450 Enzyme Induction and Inhibition
2003
Computational Discovery of Novel Low Micromolar Human Pregnane X Receptor Antagonists
2008
Machine Learning Methods and Docking for Predicting Human Pregnane X Receptor Activation
2008
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
2012
Synthesis of a Series of 4-Benzyloxyaniline Analogues as Neuronal N-Type Calcium Channel Blockers with Improved Anticonvulsant and Analgesic Properties
1999
Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.
1998
Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition: Identification of (S)-N-[1-(4-Fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an Orally Bioavailable KCNQ2 Opener Devoid of CYP3A4 Metabolism-Dependent Inhibition
2003
Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its Analogs
2007
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
1998